The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2024

Filed:

Feb. 26, 2021
Applicant:

Verily Life Sciences Llc, South San Francisco, CA (US);

Inventors:

Daniel Freedman, Zikhron Yaaqov, IL;

Yacob Yochai Blau, Haifa, IL;

Liran Katzir, Tel Aviv, IL;

Amit Aides, Haifa, IL;

Ilan Moshe Shimshoni, Haifa, IL;

Ehud Benyamin Rivlin, Haifa, IL;

Yossi Matias, Tel Aviv, IL;

Assignee:

Verily Life Sciences LLC, South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06T 7/50 (2017.01); A61B 1/00 (2006.01); G06V 10/764 (2022.01); G06V 10/82 (2022.01); G06V 20/64 (2022.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01);
U.S. Cl.
CPC ...
A61B 1/000096 (2022.02); G06T 7/50 (2017.01); G06V 10/764 (2022.01); G06V 10/82 (2022.01); G06V 20/647 (2022.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01); G06T 2207/10068 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/20084 (2013.01); G06T 2207/30032 (2013.01);
Abstract

The present disclosure is directed towards systems and methods that leverage machine-learned models to decrease the rate at which abnormal sites are missed during a gastroenterological procedure. In particular, the system and methods of the present disclosure can use machine-learning techniques to determine the coverage rate achieved during a gastroenterological procedure. Measuring the coverage rate of the gastroenterological procedure can allow medical professionals to be alerted when the coverage output is deficient and thus allow an additional coverage to be achieved and as a result increase in the detection rate for abnormal sites (e.g., adenoma, polyp, lesion, tumor, etc.) during the gastroenterological procedure.


Find Patent Forward Citations

Loading…